cellular
• 4- to 15-fold increase of glycosaminoglycan content in tissues of 6-month-old mice
|
cardiovascular system
• heart valves show considerable thickening
|
• mitral valve thickening is detected by echocardiography in 4 of 10 mutants
|
• leaflets shows an enlargement of cells that contain vacuoles and a higher cell number
|
• the cardiac output is almost half of wild-type
|
• fractional shortening of the myocardium is reduced to about 2/3 of wild-type
• the left ventricular diameter at the end of systole is enlarged while the left ventricular diameter at the end of diastole is not changed
|
• 2 of the 4 mutants with mitral valve thickening show mitral regurgitation
|
• the systolic and diastolic functional properties of hearts are severely impaired
• significantly lower velocity of blood flow and reduction in pressure gradients across the aortic and mitral valves
• impaired diastolic properties are shown by a reduction of the Vmax of the mitral E-wave of 38% representing the impaired diastolic filling of the left ventricle
|
vision/eye
• exhibit corneal alterations that range from mild disarrangement of fibrils to severe stromal disarray with large fissures
• however, homozygotes do not develop corneal clouding as is frequently observed in MPS VI patients
|
• in most cases, corneal epithelium shows reduced thickness and loss of the typical cell alignment
|
muscle
• fractional shortening of the myocardium is reduced to about 2/3 of wild-type
• the left ventricular diameter at the end of systole is enlarged while the left ventricular diameter at the end of diastole is not changed
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
mucopolysaccharidosis VI | DOID:12800 |
OMIM:253200 |
J:102290 |